Adverse event,
n (%)
Sugammadex 4.0 mg/kg
(n=51)
Neostigmine 50 μg/kg (n=49)
Procedural pain 41 (80.4) 38 (77.6)
Nausea 26 (51.0) 24 (49.0)
Vomiting 9 (17.6) 11 (22.4)
Incision-site pain 7 (13.7) 9 (18.4)
Constipation 6 (11.8) 6 (12.2)
Headache 3 (5.9) 7 (14.3)
Pyrexia 7 (13.7) 2 (4.1)
Dizziness 6 (11.8) 2 (4.1)
Pruritus 3 (5.9) 5 (10.2)
Table 4: Adverse events occurring in at least 10% of patients in either treatment group, regardless of relationship to study drug (all-subjects-treated group, n=100).